Area of Focus: Oncology

Nanogrow Biotech is developing a new generation of biological treatments for immune disorders and oncology. Their technological platform combines the efficacy of antibodies with the safety and simplicity of localized application, reaching targets that monoclonal antibodies cannot. This is made possible through the use of camelid-derived nanobodies, the smallest, simplest, and most stable antibodies.